Cardiac Microcatheter Market Report | Size & Share 2028
心脏微导管市场规模预计将从 2022 年的 3.3297 亿美元增至 2028 年的 4.872 亿美元。预计 2023 年至 2028 年的复合年增长率为 6.8%。microcatheter market is projected to reach US$ 487.20 million by 2028 from US$ 332.97 million in 2022. It is expected to register a CAGR of 6.8% from 2023 to 2028.
分析师观点
心血管疾病患病率的上升和经皮冠状动脉介入治疗的使用率的提高推动了心脏微导管市场的增长。患有慢性病的患者数量不断增加以及研发活动的增加是推动心脏微导管市场发展的关键因素。此外,心脏微导管市场的主要参与者正专注于战略举措,通过推出新产品来扩大其地理覆盖范围并增强满足庞大客户群的能力。例如,2023 年 5 月,Acotec Scientific Holdings Ltd. 获得了其微导管 Vericor-14 的中国营销批准,以协助经皮冠状动脉介入治疗和经皮外周介入治疗,在竞争激烈的市场中领先一步,到本世纪末,该市场有望增长八倍。percutaneous coronary intervention drive the microcatheter marketmicrocatheter. Furthermore, the cardiac microcatheter market key players are focusing on strategic initiatives by launching new products to expand their geographic reach and enhance capacities to cater to a large customer base. For instance, in May 2023, Acotec Scientific Holdings Ltd. received Chinese marketing approval for its microcatheter Vericor-14 to assist in percutaneous coronary interventions and percutaneous peripheral interventions, taking a step ahead in a competitive market that is poised to grow eightfold by the end of the decade.
市场概况
心脏微导管是介入心脏病学手术中用于进入和治疗各种心血管疾病的专用设备。这些微导管旨在精确控制地穿过心脏及其血管的复杂解剖结构。心脏微导管用于各种手术,包括血管成形术、血管造影术、动脉粥样硬化切除术和血栓切除术,以及放置支架或其他设备。它们可以进入冠状动脉,并可以输送治疗剂或设备来治疗阻塞、狭窄或其他异常。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
心脏微导管市场:
Cardiac Microcatheter Market: Strategic Insights
Cardiac Microcatheter Market
-
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cagr.png)
CAGR (2022 - 2028)
6.8%
-
Market Size 2022
US$ 332.97 Million
-
Market Size 2028
US$ 487.20 Million
Market Dynamics
GROWTH DRIVERS
- 心血管疾病发病率高
- 经皮冠状动脉介入治疗(PCI)在治疗慢性完全闭塞性血管病(CTO)中的应用日益广泛
FUTURE TRENDS
- 心脏微导管领域新产品审批、上市和认知度激增
OPPORTUNITIES
- 医疗支出增加和政府主导的心脏健康举措
Key Players
- Boston Scientific Corp
- Teleflex Inc
- Medtronic Plc
- OrbusNeich Medical Group Holdings Ltd
- Asahi Intecc USA Inc
- Merit Medical Systems Inc
- Nipro Corp
- Terumo Corp
- Tokai Medical Products Inc
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
适应症(一般外周血管及冠状动脉)
最终用户(医院、专科诊所和门诊手术中心)
Cardiac Microcatheter Market: Strategic Insights
-
CAGR (2022 - 2028)6.8% -
Market Size 2022
US$ 332.97 Million -
Market Size 2028
US$ 487.20 Million
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
Market Dynamics
- 心血管疾病发病率高
- 经皮冠状动脉介入治疗(PCI)在治疗慢性完全闭塞性血管病(CTO)中的应用日益广泛
- 心脏微导管领域新产品审批、上市和认知度激增
- 医疗支出增加和政府主导的心脏健康举措
Key Players
- Boston Scientific Corp
- Teleflex Inc
- Medtronic Plc
- OrbusNeich Medical Group Holdings Ltd
- Asahi Intecc USA Inc
- Merit Medical Systems Inc
- Nipro Corp
- Terumo Corp
- Tokai Medical Products Inc
Regional Overview
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
复合年增长率(2022 - 2028)6.8%- 2022 年市场规模
3.3297 亿美元 - 2028 年市场规模
4.872 亿美元
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
市场动态
- 心血管疾病发病率高
- 经皮冠状动脉介入治疗 (PCI) 在治疗慢性完全闭塞性血管病 (CTO) 中的应用日益广泛
- 心脏微导管领域新产品审批、上市和认知度激增
- 医疗支出增加和政府主导的心脏健康举措
关键人物;主力;重要一员
- 波士顿科学公司
- 泰利福公司
- 美敦力公司
- OrbusNeich 医疗集团控股有限公司
- 朝日Intecc美国公司
- 梅里特医疗系统公司
- 尼普洛公司
- 泰尔茂公司
- 东海医疗产品公司
区域概况
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
- 一般外周血管和冠状动脉
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- 医院
- 专科诊所
- 门诊手术中心
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
市场驱动因素
心血管疾病患病率上升推动全球心脏微导管市场发展
根据世界卫生组织 (WHO) 的数据,心血管疾病是全球发病率和死亡率的最主要原因。心血管疾病包括脑血管病、冠心病和风湿性心脏病。导致心血管疾病和相关问题的主要生活方式因素包括吸烟、不健康饮食和缺乏运动等。与心血管疾病相关的其他风险因素包括高血压、糖尿病和胆固醇水平升高。心脏病发作和中风主要是由脂肪沉积物阻塞血管,阻断流向心脏或大脑的血液引起的。根据美国心脏协会的报告,2020年全球约有1900万人死于心血管疾病,比2010年增长了18.7%。缺血性心脏病是心血管死亡的最常见原因,2020年夺走了超过940万人的生命和1.85亿伤残调整生命年,而缺血性中风、脑出血、高血压心脏病和风湿性心脏病位列前五大死因。
根据美国心脏协会的数据,2020 年记录的心血管疾病相关死亡人数从 2019 年的 874,613 人增加到 928,741 人。2018 年至 2019 年,心血管疾病的直接和间接总成本为 4073 亿美元(直接成本 2514 亿美元,生产力损失/死亡率 1559 亿美元)。2020 年,冠心病是美国心血管疾病死亡的主要原因(41.2%),其次是中风(17.3%)、高血压(12.9%)、心力衰竭(9.2%)、动脉疾病(2.6%)和其他心血管疾病(16.8%)。此外,世界心脏联盟预测,到 2030 年,每年心血管疾病相关死亡人数将超过 2300 万。
根据欧洲心脏病学会 2020 年发布的一项研究《中欧和东欧心血管疾病》,心血管疾病是欧洲的主要死亡原因,占所有死亡人数的 45%。由于吸烟习惯和大量饮酒,心血管危险因素在中欧和西欧非常普遍,尤其是男性。每年有超过 400 万欧洲人死于心血管疾病,主要是冠状动脉疾病和中风。中东的心血管疾病发病率也很高,这导致该地区对各种干预措施的需求激增,例如健康教育、生活方式咨询、筛查和治疗。根据世界心脏联盟的数据,心血管疾病是中东和北非的主要死亡原因,占所有死亡人数的三分之一以上,每年有 140 万人死于心血管疾病。此外,在过去 30 年里,心血管疾病死亡人数增加了 48%,分别占阿曼和索马里死亡人数的 40% 和 10%。 2021年,中东和北非地区年龄标准化心血管疾病死亡率为每10万人134.2至600.2人。因此,心血管疾病的高患病率正在推动心脏微导管市场的发展。
节段分析
根据适应症,心脏微导管市场细分为一般外周血管和冠状动脉。冠状动脉部分在 2022 年占据了更大的市场份额,预计在预测期内将实现 6.9% 的复合年增长率。该细分市场的市场地位归功于冠状动脉微导管提供的精度和控制。微导管非常薄且灵活,使心脏病专家能够精确且有控制地穿越复杂的冠状动脉网络。它们甚至可以到达最窄和最曲折的血管,从而实现准确诊断和有针对性的治疗。
区域分析
北美是心脏微导管市场的主导地区。2022 年北美心脏微导管市场价值为 1.2755 亿美元,预计到 2028 年将达到 1.881 亿美元;预计在预测期内复合年增长率为 6.9%。北美心脏微导管市场分为美国、加拿大和墨西哥。区域市场增长归因于心脏病(包括心血管疾病、中风等)发病率不断上升以及医疗保健基础设施发达等因素。大量患者和医疗保健专业人员对治疗心脏疾病的微创手术的高度偏好预计将在预测期内促进心脏微导管市场的增长。
心脏微导管市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 3.3297亿美元 |
2028 年市场规模 | 4.872亿美元 |
全球复合年增长率(2022 - 2028) | 6.8% |
历史数据 | 2020-2021 |
预测期 | 2023-2028 |
涵盖的领域 | 按适应症
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
关键球员分析
波士顿科学公司、Teleflex Inc、美敦力公司、OrbusNeich 医疗集团控股有限公司、Asahi Intecc USA Inc、Merit Medical Systems Inc、Nipro Corp、Terumo Corp、Tokai Medical Products Inc 和 Integer Holdings Corp 是心脏微导管市场的主要参与者。在这些参与者中,美敦力公司和波士顿科学公司因其提供多样化的产品组合而位居前两位。
最近的发展
心脏微导管市场中的公司普遍采用并购等无机和有机策略。以下列出了一些近期的关键市场发展:
- 2019 年,iVascular 的新型冠状动脉微导管 Navitian 获得了 CE 标志认证。该设备获准用于在进入冠状动脉系统、更换导丝以及注射不透射线造影剂或盐水溶液时辅助、引导和支持导丝。
- 2020 年,Bracco 集团旗下公司 Acist Medical Systems Inc. 宣布在全球推出 Acist Navvus II Rapid Exchange血流储备分数 (FFR) 微导管,这是与其 Acist RXi Rapid Exchange FFR 系统配合使用的第二代微导管。FFR 测量可评估动脉病变的严重程度以及诊断和治疗冠状动脉疾病的干预策略。
- 2021 年,Baylis Medical 在欧洲推出了 JLL 2-French 电生理微导管的首例临床案例。此次发布使医生能够到达以前无法到达的心脏区域进行手术映射,从而推出欧洲市场上最小的诊断导管。2F 微导管还允许在较小的解剖结构(例如 Marshall 静脉)中进行映射和起搏。
- 2023 年,阿联酋的 Al Qassimi 医院与飞利浦合作,让中东、土耳其和非洲的更多患者能够接受超低对比度经皮冠状动脉介入治疗 (ULC-PCI)。Al Qassimi 医院的新 ULC-PCI介入心脏病学 课程是飞利浦全球教育计划的一部分,旨在分享有关可为冠状动脉疾病提供低对比度、微创治疗的技术的知识,从而提高患者的认知度。
Cardiac Microcatheter Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 332.97 Million |
Market Size by | US$ 487.20 Million |
Global CAGR | 6.8% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 适应症(一般外周血管及冠状动脉) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Medtronic Plc and Boston Scientific Corporation. are the top two companies that hold huge market shares in the cardiac microcatheter.
Microcatheter is defined as a small diameter catheter that is used in minimally invasive procedures for delivering devices. Its small build makes it ideal for navigating complex vasculature within the human body. It is used for guidewire support, exchanges, to access distal anatomy, cross lesions, deliver therapeutic embolic, inject contrast media, and perform other procedures in complex endovascular procedures. Microcatheters are also commonly used in percutaneous coronary intervention (PCI). The growth is attributable to the increasing prevalence of cardiovascular diseases and the growing use of percutaneous coronary intervention (PCI) for treating chronic total occlusions (CTO).
The hospitals segment dominated the cardiac microcatheter and held the largest market share in 2022.
The Cardiac microcatheter majorly consists of the players such as Boston Scientific Corp, Teleflex Inc, Medtronic Plc, OrbusNeich Medical Group Holdings Ltd, Asahi Intecc USA Inc, Merit Medical Systems Inc, Nipro Corp, Terumo Corp, Tokai Medical Products Inc, Integer Holdings Corp, and among others. .
The CAGR value of the cardiac microcatheter during the forecasted period of 2023-2028 is 6.8%.
Coronary segment held the largest share of the market in the cardiac microcatheter and held the largest market share in 2022.
Key factors that are driving the growth of this market are increasing prevalence of cardiovascular diseases and the growing use of percutaneous coronary intervention (PCI) for treating chronic total occlusions (CTO).
The List of Companies - Cardiac Microcatheter Market
- Boston Scientific Corp
- Teleflex Inc
- Medtronic Plc
- OrbusNeich Medical Group Holdings Ltd
- Asahi Intecc USA Inc
- Merit Medical Systems Inc
- Nipro Corp
- Terumo Corp
- Tokai Medical Products Inc
- Integer Holdings Corp.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.